Tradestie Institutional Equity Comparison Engine

MATR vs MMSI โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

MMSI Overall Edge

MMSI Captures Institutional Edge (4โ€“0 Pillars ยท 9โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Merit Medical Systems Inc (MMSI) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, MATR trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus MMSI at 18.5x Forward P/E and 13.9% operating margin (+8.4% YoY). In options structure, MATR sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against MMSI sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner MMSI
MATR N/M vs MMSI 18.5x Fwd P/E
Growth & Margin Winner MMSI
Op Margin N/A vs 13.9% ยท YoY N/A vs +8.4%
Momentum & Technical Winner MMSI
1Y -6.5% vs -1.2% ยท 52W Pos 3% vs 76%
Options & Structure Winner MMSI
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (<1st %ile IV)
MATR US Equity
MATR
Institutional Equity
$26.23
-1.72% 1D
Market Cap N/A
1M Return -4.21%
1Y Return -6.49%
Forward P/E N/M
Unified AI Score
47.4 / 100 HOLD
Tech 50.0 Fund 50.0 Flow 50.0 Mom 60.0
MMSI NASDAQ
Merit Medical Systems Inc
Surgical & Medical Instruments & Apparatus
$86.35
-0.32% 1D
Market Cap $5.2B
1M Return -3.2%
1Y Return -1.2%
Forward P/E 18.5x
Unified AI Score
61.4 / 100 BUY
Tech 58.0 Fund 53.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: MATR -6.49% MMSI -1.2% Spread: +1.74 pp (MMSI Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
MATR TTM Op. Margin: N/A MMSI TTM Op. Margin: 13.9%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MATR vs MMSI. Trailing 12-month operating profitability (MATR N/A vs MMSI 13.9%) and valuation multiples (MATR N/M vs MMSI 18.5x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: MATR (1) vs MMSI (9)
Institutional Metric MATR MMSI Criterion Row Winner
Market Capitalization Scale N/A $5.2B Larger Scale MMSI
Trailing P/E Ratio Valuation N/M 32.5x Lower Multiple MMSI
Forward P/E Ratio Valuation N/M 18.5x Lower Multiple MMSI
Revenue Growth (YoY) Growth N/A +8.4% Higher Growth MMSI
Operating Margin (TTM) Profitability N/A 13.9% Higher Margin MMSI
Net Profit Margin Profitability N/A 9.9% Higher Margin MMSI
Return on Equity (ROE) Capital Efficiency N/A 9.8% Higher ROE MMSI
52-Week Range Position Momentum 3% ($26โ€“$28) 76% ($60โ€“$95) Stronger Trend MMSI
Beta / 30D Volatility Risk Regime 0.86ฮฒ ยท 19% Vol 0.49ฮฒ ยท 44% Vol Lower Realized Risk MATR
Unified Institutional Score Composite Signal 47.4 / 100 (HOLD) 61.4 / 100 (BUY) Higher Composite MMSI

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full MATR vs MMSI Buy Guide
MATR UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live MATR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
MMSI UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live MMSI Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither MATR nor MMSI registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.